Erlotinib (Tarceva) in patients with non-small-cell lung cancer (NSCLC)): results on 394 patients from Tarceva Registr of Czech Republic

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	SKŘIČKOVÁ Jana PEŠEK Miloš ZATLOUKAL Petr KOLEK Vítězsla KOUBKOVÁ Leona SALAJKA František ZEMANOVÁ Milada TOMÍŠKOVÁ Marcela SIXTOVÁ Dimka PAVLÍK Tomáš
Year of publication	2009
Type	Article in Periodical
Magazine / Source	Journal of Thoracic Oncology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	non-small cell ling cancer; erlotinib; Tarceva register; Czech Republic
Description	394 patients with non-small-cell lung cancer have been fed into the Erlotinib(Tarceva)register in the Czech Republic and followed up continually
Related projects:	Environment - carcinogenesis - oncology